These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17668764)

  • 41. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting.
    Prettyjohns M; Sandelin R; Lister S; Norrefalk JR
    J Med Econ; 2012; 15(6):1097-109. PubMed ID: 22712872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic advances in pharmaceutical treatment of neuropathic pain].
    Attal N
    Rev Neurol (Paris); 2011 Dec; 167(12):930-7. PubMed ID: 22100325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Reducing pain by new forms of therapy].
    Baron R
    Krankenpfl J; 2004; 42(7-10):224-5. PubMed ID: 15675388
    [No Abstract]   [Full Text] [Related]  

  • 45. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; Rejas J
    Pain Med; 2012 May; 13(5):699-710. PubMed ID: 22594706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregabalin (Lyrica) for fibromyalgia.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):77-8. PubMed ID: 17878888
    [No Abstract]   [Full Text] [Related]  

  • 47. [Interview with Prof. Dr. Ralf Baron. Pain: toward causality oriented therapy].
    Baron R
    MMW Fortschr Med; 2014 Nov; 156(19):85. PubMed ID: 25510032
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
    Baron R; Brunnmüller U; Brasser M; May M; Binder A
    Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions.
    Gilron I
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):456-72. PubMed ID: 17873599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuropathic pain. Basic principles for successful therapy].
    Tölle TR; Baron R
    MMW Fortschr Med; 2002 May; 144(21):41-4. PubMed ID: 12134424
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pregabalin improves pain and important comorbidities].
    MMW Fortschr Med; 2014 Jun; 156(12):59. PubMed ID: 25369690
    [No Abstract]   [Full Text] [Related]  

  • 53. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
    Guay DR
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series.
    Harnack D; Scheel M; Mundt A; Kupsch A; Heinz A; Ströhle A
    J Clin Psychopharmacol; 2007 Oct; 27(5):537-9. PubMed ID: 17873703
    [No Abstract]   [Full Text] [Related]  

  • 55. Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information.
    Härmark L; van Puijenbroek E; Straus S; van Grootheest K
    Drug Saf; 2011 Mar; 34(3):221-31. PubMed ID: 21332246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo.
    Bauer CS; Rahman W; Tran-van-Minh A; Lujan R; Dickenson AH; Dolphin AC
    Biochem Soc Trans; 2010 Apr; 38(2):525-8. PubMed ID: 20298215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pregabalin. A new treatment for neuropathic pain].
    López-Trigo J; Sancho Rieger J
    Neurologia; 2006 Mar; 21(2):96-103. PubMed ID: 16525916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial.
    Olesen SS; Bouwense SA; Wilder-Smith OH; van Goor H; Drewes AM
    Gastroenterology; 2011 Aug; 141(2):536-43. PubMed ID: 21683078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregabalin (lyrica) for neuropathic pain and epilepsy.
    Med Lett Drugs Ther; 2005 Sep; 47(1217):75-6, 73. PubMed ID: 16151369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.